TWD 25.65
(9.85%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 53.4 Million TWD | 151.99% |
2022 | 21.19 Million TWD | -18.12% |
2021 | 25.88 Million TWD | 282.63% |
2020 | 6.76 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 68.88 Million TWD | 29.0% |
2024 Q2 | 69.68 Million TWD | 1.16% |
2023 FY | 53.4 Million TWD | 151.99% |
2023 Q1 | 15.41 Million TWD | -27.26% |
2023 Q2 | 55.22 Million TWD | 258.23% |
2023 Q4 | 53.4 Million TWD | 0.0% |
2022 Q4 | 21.19 Million TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 90.848% |
Level Biotechnology Inc. | 273.2 Million TWD | 80.454% |
Sagittarius Life Science Corp | 137.82 Million TWD | 61.254% |
NeoCore Technology Co., Ltd. | 197.47 Million TWD | 72.958% |
TaiMed Biologics Inc. | 1.32 Billion TWD | 95.978% |
GlycoNex Incorporation | 276.39 Million TWD | 80.68% |
VBI | 21.25 Million TWD | -151.287% |
GeneReach Biotechnology Corp. | 313.7 Million TWD | 82.977% |
Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 89.624% |
Visgeneer Inc. | 185.6 Million TWD | 71.229% |
Mycenax Biotech Inc. | 1.32 Billion TWD | 95.964% |
Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 92.715% |
G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 55.447% |
Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 97.622% |
TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -706.905% |
Enimmune corporation | 173.46 Million TWD | 69.215% |
TaiRx, Inc. | 60.62 Million TWD | 11.916% |
CHO Pharma, Inc. | 110.83 Million TWD | 51.818% |
EirGenix Inc. | 1.14 Billion TWD | 95.337% |
BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 52.312% |
Sunny Pharmtech Inc. | 512.43 Million TWD | 89.579% |
Lin BioScience, Inc. | 167.73 Million TWD | 68.163% |
BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | 43.017% |
Feng Chi Biotech Corp. | 63.03 Million TWD | 15.282% |
Bio Preventive Medicine Corp. | 124.72 Million TWD | 57.186% |
Lukas Biomedical Inc. | 161.05 Million TWD | 66.844% |
RBC Bioscience Corporation | 513.08 Million TWD | 89.592% |
BiOptic Inc. | 170.56 Million TWD | 68.691% |
BRIM Biotechnology, Inc. | 42.15 Million TWD | -26.669% |
Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -129.632% |
Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -99.161% |
Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 94.521% |
Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -663.526% |
SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -151.583% |
Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 85.502% |
Neith Corporation | 17.43 Million TWD | -206.321% |
Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -569.857% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 88.909% |
Sinew Pharma Inc. | 39.71 Million TWD | -34.464% |
Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | 7.991% |
Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 85.349% |
Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 76.547% |
AP Biosciences Inc | 106.65 Million TWD | 49.929% |
Medigen Biotechnology Corp. | 3.53 Billion TWD | 98.487% |
3D Global Biotech Inc. | 30.68 Million TWD | -74.052% |
Pharmosa Biopharm Inc. | 195.99 Million TWD | 72.753% |
Intech Biopharm Corporation | 1.54 Billion TWD | 96.54% |
Oneness Biotech Co., Ltd. | 866.42 Million TWD | 93.837% |
Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -475.69% |
TWi Biotechnology, Inc. | 55.81 Million TWD | 4.322% |
Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 77.077% |
TCI GENE Inc. | 155.54 Million TWD | 65.669% |
MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -109.35% |
Senhwa Biosciences, Inc. | 46.17 Million TWD | -15.649% |
Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 83.743% |
NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | 17.702% |
PharmaEngine, Inc. | 91 Million TWD | 41.321% |
Savior Lifetec Corporation | 457.95 Million TWD | 88.339% |
TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 51.865% |
OBI Pharma, Inc. | 650.44 Million TWD | 91.79% |
Meribank Biotech Co., Ltd | 390.81 Million TWD | 86.336% |
Acepodia, Inc. | 384.47 Million TWD | 86.111% |
Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | 37.581% |